Aptadel Therapeutics

A BIOMEDICAL COMPANY FOCUSED ON DEVELOPING RNA
TECHNOLOGIES TO DELIVER THERAPEUTICS INTO CANCER CELLS.

The Company

Aptadel Therapeutics is a pre-clinical stage drug development biotech company exploiting RNA Aptamer technologies for the treatment of cancer. The company’s lead program is focused on Ewing Sarcoma Sarcoma, a pediatric cancer with low life expectancy.

 

Our Aptamer technology is a multifunction delivery tool of different therapeutic agents (siRNA, miRNA, chemotherapeutic drugs and small molecules) that can be customized for several indications.

We work towards finding successful treatments to a wide variety oncology indications.The Company is a spin off from IDIBELL, also co-founded by Fundación Alba. It is based in the Parc Cientific de Barcelona (PCB).